Rheumnow Podcast

Spondyloarthritis: The CLASSIC Study  "Leftover Pain in Inflammatory Arthritis"  NeuroImmune Modulation in RA: Results of the RESET RA Trial  Change it or Keep it? TNF in Axial SpA  Perspectives on CAR T Therapy  Addressing Lupus Nephritis Early  Addressing Lupus Nephritis Aggressively  CAR-T: The Future  Biomarker Discovery in axSpA  Another Specialized Biomarker in PsA  Revised Classification Cr...

Catching AxSpA Early: Closing the Diagnostic Gap  Early Peripheral SpA: Is it okay to stop treatment sometimes?  Difficult to Manage axSpA  Tofacitinib in AxSpA in Developing Countries  Late-Breaking Trials in axSpA and PsA  Durability and Safety of Bimekizumab  Biologics Improve Sexual Function in axSpA  Multidimensional Pain inventory in Axial SpA  Spondyloarthritis: The CLASSIC Study  Change it...

B Cell Depletion: Check the Lymph Node  "Next Generation T-Cell Engager: The Future"  Off the Shelf: CAR-T  Combining CAR-T with CAR-Treg All in One  CAR-T Therapy: Where is it Heading?  Safety of CAR-T  New Paradigms in RA Treatment  Perspectives on CAR T Therapy 

Wired for Success: Vagal Nerve Therapy in RA  RA: Does upfront TNFi save heartache?  New Paradigms in RA Treatment 

SLGT-2 and GLP-1 in RA: More than Weight Loss  ACR2025 Day 1 RECAP 

Cellular Biomarkers of Rheumatoid Arthritis  Day 2 Recap: ACR Convergence 2025 Highlights

STOP RA Cellular & Serologic Predictors  Rheumatoid Arthritis: Inject the Steroids  Is Low Disease Activity Low Enough? 

Catching PsA before it Starts  Day 2 Recap: ACR Convergence 2025 Highlights 

PsA and Brain Fog  GLP-1 Receptor Agonists in PsA: Mortality and MACE  PsA Predictors  When the Back Hurts: uncovering BASDAI drivers in PsA The Upper Hand in PsA? Not the Dominant One

Diagnostic Delays in PsA: A Radiographic Perspective  Late-Breaking Trials in axSpA and PsA  New Approaches to Therapy in PsA 

Psoriatic Arthritis Imaging  Specialized Biomarkers in PsA  PsA: Impact of Sex  GLP-1 and SGLT-2: Treatments Too Good to Ignore?

Safety of NSAIDs in Inflammatory Bowel Disease  Screen RA ILD Properly  Biologics Improve Sexual Function in axSpA  Catching PsA before it Starts  Multidimensional Pain inventory in Axial SpA  RA: Does upfront TNFi save heartache?  Novel Insights into Sjogren's Disease  New Paradigms in RA Treatment  Biomarkers in Still's and Macrophage Activation Syndrome  "The Power of Gamma Delta T Cell for Aut...

NSAID Addition Helps the Spine but not the Hips  Durability and Safety of Bimekizumab  Progressive BiTE in SLE 2  Hydroxychloroquine Reduces Autoantibody Levels  When the Back Hurts: uncovering BASDAI drivers in PsA  The Upper Hand in PsA? Not the Dominant One  Airway Disease in GPA  Wired for Success: Vagal Nerve Therapy in RA  GLP-1 in Knee Osteoarthritis  Disparities in Physical Function in SLE...

Putting Steroid Tapering into Practice in SLE  Tocilizumab Beats Methotrexate in GCA  GLP-1 Receptor Agonists in PsA: Mortality and MACE Safety of CAR-T  ILD in Patients with Connective Tissue Disease  SLGT-2 and GLP-1 in RA: More than Weight Loss  PsA Predictors  Ianalumab: Breakthrough Therapy in Sjogren's

Off the Shelf: CAR-T  Combining CAR-T with CAR-Treg All in One  Tapering in SELECT GCA: Steroids are the Problem  Diagnostic Delays in PsA: A Radiographic Perspective  Late-Breaking Trials in axSpA and PsA  New Approaches to Therapy in PsA  PRED-SAFE: Chronic Prednisone Use  PsA and Brain Fog  CAR-T Therapy: Where is it Heading? 

Join RheumNow Faculty Drs. David Liew, Antoni Chan,  Mrinalini Dey, and Jack Cush as they discuss highlights and key takeaways from the Day 2 Recap on Monday, October 27th, at the 2025 ACR Convergence meeting in Chicago.

A Nose for Vasculitis: ENT Manifestations in ANCA-Associated Disease  Tofacitinib in AxSpA in Developing Countries  Specialized Biomarkers in PsA  B Cell Depletion: Check the Lymph Node  GLP-1 and SGLT-2: Treatments Too Good to Ignore?  Nerandomilast for ILD  PsA: Impact of Sex  Cellular Biomarkers of Rheumatoid Arthritis  Using AI and LLMs in Qualitative Data  Belimumab Before or After Immunosupp...

AI Scribes Found their Favorite Doctors  Hospitalization in Stills: Is it "Still" an Infection? Upadacitinib is a Double Edged Vascular Sword in GCA  Rheumatoid Arthritis: Inject the Steroids Catching AxSpA Early: Closing the Diagnostic Gap  Is Low Disease Activity Low Enough?  Early Peripheral SpA: Is it okay to stop treatment sometimes? Difficult to Manage axSpA

STOP RA Cellular & Serologic Predictors Is AI Smarter than a Doctor? Lung Disease in ANCA-associated Vasculitis  Older Adults Underrepresented in RCTs  Next Generation T-Cell Engager: The Future Lupus in Focus: 2025 ACR Treatment Guidelines for SLE  Psoriatic Arthritis Imaging   

Big takeaways, standout moments, and what set the tone for this year’s conference. We break down the key insights, early trends, and conversations shaping Day 1.

Dr. Jack Cush reviews the news and info reports the day before ACR 2025.

DERM on RheumNow PODCAST (October 2025) Skin important Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, other CTD skin disorders. dermatology drugs, biiologics, JAKs - their use, efficacy and side effects. Features Dr. Jack Cush, Editor at RheumNow.com.  SHOW NOTES 1. Skin Biopsies to Predict Scleroderma Outcomes?  2. Fibromyalgia in PsO & PsA...

Dr. Jack Cush reviews the news and journal reports, discusses pediatric reports, pregnancy data, diet and nutrition and more.

Dr. Jack Cush reviews the news, journal reports and important associations in rheumatology from the past week on RheumNow.com.